Streetbeat News

Products Services

HALO

Halozyme Therapeutics has reiterated its financial guidance for 2024, projecting EPS of $3.65-$4.05 and revenue of $935M-$1.015B. This represents significant growth over 2023, driven by increases in royalty revenue, collaboration revenue, and product sales from XYOSTED®. Adjusted EBITDA is expected to grow by 30% to 44%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:13 pm

BTCUSD

Technical analysts are debating the future price action of Bitcoin (BTC) following its recent downturn. Analysts highlight the importance of flexibility in technical analysis and considering broader market factors. The influence of Bitcoin as an institutional asset will be discussed at Benzinga’s Future of Digital Assets event on Nov. 19.

Portfolio Pulse from Khyathi Dalal

August 06, 2024 | 8:12 pm

GO

Grocery Outlet has announced plans to open 62-64 new stores in the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:03 pm

BTCUSD

DJT

Eric Trump has expressed his enthusiasm for cryptocurrency and decentralized finance (DeFi) on X, hinting at a significant upcoming announcement. This could potentially impact the cryptocurrency market and related assets.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 7:47 pm

DJT

Former President Donald Trump and Tesla CEO Elon Musk are set for an interview on Monday, Aug. 12, ahead of the 2024 presidential election. The interview could be hosted on Musk's platform X (formerly Twitter) or Trump's Truth Social. The event could significantly impact Truth Social's performance and visibility.

Portfolio Pulse from Chris Katje

August 06, 2024 | 7:40 pm

DELL

Dell Technologies Inc. (NYSE:DELL) shares are trading lower following the announcement of a significant reorganization within its sales teams, including job cuts and a new focus on AI products and services. The company aims to streamline management layers and shift investment priorities towards emerging technologies. Market sentiment is mixed but leans bullish, with notable options trading activity suggesting a price range of $80.0 to $150.0 over the next three months. Dell shares fell 3.90%, trading at $94.35.

Portfolio Pulse from Vaishali Prayag

August 06, 2024 | 7:17 pm

ALK

BA

NTSB Chair Homendy has stated that Boeing has significant improvements to make in its safety culture. Additionally, the NTSB and Boeing have been unable to determine who removed a door plug from an Alaska Airlines 737 MAX 9.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 7:13 pm

DUK

U.S. Secretary of Energy Jennifer Granholm announced a $57 million DOE funding for a transmission rebuild project in North Carolina. The project, in partnership with Duke Energy and state agencies, aims to enhance power grid reliability and meet growing demand. The 40-mile transmission line rebuild in Wake, Johnston, and Wayne counties will benefit 14,000 customers.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 7:10 pm

BMRN

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has announced a strategic update focusing its Roctavian business on the U.S., Germany, and Italy, where the treatment is approved and reimbursed. The company plans to reduce annual Roctavian expenses to $60 million by 2025 and expects the treatment to be profitable by the end of that year. BioMarin reported strong Q2 results with an adjusted EPS of $0.96, beating the consensus of $0.35, and sales of $712.03 million, driven by Voxzogo and Naglazyme. The company raised its 2024 revenue guidance to $2.75-$2.825 billion and adjusted EPS guidance to $3.10-$3.25. William Blair maintains an Outperform rating on the stock.

Portfolio Pulse from Vandana Singh

August 06, 2024 | 7:06 pm

BNTX

PFE

The University of Pennsylvania has filed a lawsuit against BioNTech, alleging that the company underpaid royalties on patents used in the COVID-19 vaccine Comirnaty. This legal action could have financial implications for BioNTech and its partner Pfizer.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 6:52 pm